In recent years, there has been increased recognition of the importance of viral infections. In addition, new antiviral agents have become available. These factors have led to a marked increase in utilization of viral diagnositc services. In this review, both conventional and rapid methods for viral diagnosis are presented, with emphasis on recent advances. The antiviral agents currently available and the major drugs under investigation are also briefly discussed. It is hoped that this review will serve as a useful adjunct for the management of patients with virus infections.
Despite the prevalence of viral infections, viral diagnostic laboratories have traditionally existed only as part of either regional health departments or university research laboratories. Conventional viral diagnostic methods have been considered time-consuming, expensive and inaccessible to the practising physician (Herrmann, 1974; Herrmann and Herrmann, 1976; Hsiung, 1977) . Thus an accurate viral diagnosis was infrequently attempted. However, in recent years the importance of viral infections has been increasingly recognized particularly as a cause of morbidity and mortality in the immunosuppressed patient (Muller et al., 1972; Ho, 1977; Shields et al., 1985) , of both severe and subtle disease in the neonate (Stagno et al., 1975; Whitley et al., 1980b) , as well as a cause of venereal disease (Ng et al., 1970; Jordon et al., 1973; Handsfield et al., 1985) . The epidemic of acquired immunodeficiency syndrome (AIDS) has focused the world's attention on viruses as potentially serious pathogens (Barre-Sinoussi et al., 1983; Popovic et al., 1984; Shaw et al., 1984) . In addition, viruses may be etiologically linked to cancer (Rawls et al., 1969; Henle et al., 1969; Hanto et al., 1981; Andiman et al., 1983; Durst et al., 1983; Wong-Staal, 1983) . Most importantly, promising new antiviral agents are becoming available. Therapy, if it is to be effective, must be instituted early in the course of the disease; thus, there has been increasing interest in viral diagnosis and particularly in the development of more rapid diagnostic procedures for viral infections (Gardner, 1977; Yolken, 1980; Richman et al., 1984a,b) .
The awareness on the part of the medical community and the public of the significance of herpes infections in particular has led to the establishment of viral diagnostic laboratories in an increasing number of community hospitals and a tremendous increase in utilization of viral diagnostic services previously available in regional laboratories or university hospitals. There has also been a burgeoning of commercial laboratories offering viral diagnostic tests to those hospitals or practitioners without such services readily available. The number of commercial companies and products available to aid in viral diagnosis has also greatly increased. With the advent of antiviral therapy, it is no longer acceptable for lack of accurate viral diagnosis to hinder or delay the treatment of patients. Thus, physicians are beginning to demand laboratory diagnosis of their patients' illnesses in order to have specific and proper treatment. To accomplish this, viral diagnostic facilities are becoming more accessible and, additionally, health practitioners must be more knowledgeable regarding procedures used for viral diagnosis. The purpose of this review, therefore, is to discuss both new and standard methods for virus recognition and identification with special reference to rapid diagnosis and the advances made in the last few years. The selection of antiviral agents currently used is also briefly discussed. It is hoped that this review will serve as a useful adjunct for the management of patients with virus infections.
NEW AND STANDARD METHODS FOR VIRUS RECOGNITION AND IDENTIFICATION
Conventional methods of viral diagnosis consist of virus isolation and serology; light and electron microscopy are performed in certain situations. Although there is tremendous interest in the development of rapid diagnostic techniques, conventional diagnostic methods remain the most widely used and are essential in confirming the usefulness of newer techniques. However, it must be emphasized that only standard virus isolation and electron microscopy allow for success in recognition of unexpected or 'new' viruses.
SPECIMEN COLLECTION
The critical first step in making a successful viral diagnosis is obtaining the proper specimens. This includes the choice of specimens, and proper collection and transport. If these initial steps are not appropriately undertaken, the subsequent time and effort spent in attempting virus isolation will be wasted.
The choice of specimens depends upon the clinical syndrome and the viruses suspected. Since one syndrome can be associated with many viruses, a set of specimens is often recommended. In general, specimens for virus isolation should be collected early in illness as many viruses are excreted for only a few days. However, certain viruses, such as cytomegalovirus (CMV), enteroviruses and adenoviruses, can be excreted for prolonged periods. Table 1 contains the commonly encountered clinical syndromes, the associated viruses and the appropriate specimens to be obtained. For throat swabs, a vigorous swab of the posterior pharynx and of any visible lesions should be obtained. Stool specimens are preferred over rectal swabs because the larger sample size results in greater yield of virus isolates. First-voided morning urines are best and two or three specimens are optimal for CMV isolation. Aspiration of nasopharyngeal mucus has been found to be superior to nasal swabs or nasal washes for isolation for respiratory syncytial virus (RSV) (Bromberg et al., 1984) and bronchoalveolar lavage specimens have been found superior to bronchial washings for CMV (Stover et al., 1984; Martin and Smith, 1986 ).
SPECIMEN TRANSPORT
Since viruses are obligate intracellular organisms, they require living cells in which to replicate. As a result, a significant decrease in virus infectivity titer will occur if clinical specimens are allowed to stand for any period at room temperature. For best results, direct inoculation of cell cultures at the bedside should be done. Generally this is not feasible, therefore swabs and tissues should be placed in viral transport media containing a balanced salt solution and a protein stabilizer, gelatin or calf serum. A variety of collection and Throat swab, stool, CSFt *Acute and convalescent sera to be collected in each case. tCerebrospinal fluid. transport devices are now available commercially and have been the subject of several recent studies (Johnson et al., 1984; Warford et al, 1984) . Urine, stools, spinal fluids and other body fluids should be placed in sterile containers. Prompt transport to the laboratory is imperative. If a delay is necessary, specimens can be held at 4°C until inoculation into cell culture. If a long delay is necessary, specimens should be frozen at -70°C. For transport to a distant laboratory, specimens can be shipped by rapid delivery service on wet ice; frozen samples can be shipped on dry ice. If swabs dry out or specimens are left at room temperature for any period, virus infectivity will deteriorate markedly. Serum is usually obtained for serodiagnosis and is helpful if no virus is isolated or to confirm an unusual isolate. Whole blood or leukocytes can also be useful in virus isolation, e.g. for CMV or Epstein-Barr virus.
VIRUS ISOLATION
Once specimens arrive in the laboratory, they must be inoculated promptly into sensitive test systems. Since viruses require living cells in which to replicate, the inoculation of cell cultures or laboratory animals is necessary. Unfortunately, no single culture system will support the growth of all viruses. Thus a variety of cell cultures are routinely used in a diagnostic laboratory. In certain circumstances, embryonated eggs or small animals may be utilized. It is apparent that laboratory personnel must know the clinical syndrome and/or the viruses suspected in order to choose the appropriate system. If an insensitive system is utilized, it is unlikely that any virus will be isolated even though virus is present in the specimen.
Cell Cultures
It was the discovery that poliovirus could replicate in nonneural tissue culture (Enders et al., 1949) that revolutionized diagnostic virology. Currently, cell cultures are the mainstay of most viral diagnostic laboratories and, for many labs, they are the only system employed. Embryonated eggs, small animals and serology are reserved for the larger reference laboratories. There has been a proliferation in the types of cell culture available. In general, three main types of cell culture are used: primary cell cultures, diploid cell strains and continuous cell lines. Primary cell cultures are made directly from animal or human tissues and can be subpassaged only a few times. Diploid cell strains are generally derived from human embryonic tissues, particularly embryonic lung, and can be subcultured for about 50 passages. Continuous cell lines are usually derived from human or animal tumors and can be propagated indefinitely. A wide variety of primary cell cultures (e.g. monkey kidney, rabbit kidney), human diploid fibroblast (HDF) cell strains (e.g. WI-38, MRC-5) and continuous cell lines (e.g. HeLa, HEp-2) are now available commercially. The choice of types of cell cultures employed in any laboratory is dependent upon the viruses sought, the patient population and the economic constraints. A fairly broad spectrum of viruses can be cultured if one set of the following cell cultures are used: primary monkey kidney (MK), HDF and HEp-2 cells. The use of several cell types facilitates the chances of recovering a variety of virus types from clinical specimens.
Recognition of Virus-Induced Cellular Changes
After inoculation into cell culture, the presence of a virus may be detected in several ways. Most commonly, virus-induced changes such as rounded refractile cells or grape-like clusters are noted ( Fig. 1 , C-H). These changes are called cytopathic effect (CPE) and vary depending on the causative virus. The formation of syncytia is characteristic of certain viruses, such as respiratory syncytial virus and measles, as well as parainfluenza types 2 and 3 when inoculated in continuous cell lines ( Fig. 1, J) . Some viruses produce no visible change, therefore indirect tests for their presence are necessary. For influenza and parainfluenza viruses, the hemadsorption test is utilized whereby a dilute solution of guinea-pig red blood cells is added to the infected monolayer of cells, allowed to adsorb at 4°C, then washed off. If influenza or parainfluenza is present, the red cells will adhere to the infected cell monolayer (Fig. 1, I ). For rubella virus, the interference test has traditionally been used. By this method, cell cultures infected with suspected rubella virus are superinfected with an echovirus, a virus that readily produces CPE. In the presence of rubella, however, the expected virus-induced CPE does not develop but is interfered with. The speed of appearance and progression of CPE can also be helpful in distinguishing viruses; however, this is also dependent upon the concentration of virus in the inoculum and the sensitivity of the particular cell culture used. Preliminary identification of a virus isolate can be made based upon the type o~" cell culture the virus is growing in and the character of the virus-induced cellular changes. For example, cytomegalovirus induces CPE only in human fibroblast cells, whereas herpes simplex virus (HSV) induces CPE in both human fibroblast and rabbit kidney (RK) cells (Fig. 2 ). Final identification usually requires a neutralization test using type-specific antiserum; however, in many laboratories more rapid methods of identification are now being applied, such as immunofluorescence (IF) with monoclonal antibodies (see Section 2.6).
THE USE OF MINI-LABS AND REFERENCE LABORATORIES
Several reports have demonstrated the feasibility of using mini or satellite laboratories, whose services are tailored to both the facilities of the laboratory and to the needs of the patient population they serve (Herrmann and Herrmann, 1977; Peterson et al., 1980; Landry and Hsiung, 1981) . For example, the cost of virus isolation can be significantly reduced by the use of microtiter plates containing different types of cell cultures. Virus isolation using the latter system compares favorably with standard techniques (Herrmann and Herrmann, 1977) . Peterson et al. (1980) reported the advantage of using satellite laboratories. Time in reporting results was reduced when primary virus isolation was performed in a local, small, hospital-based laboratory when compared with sending specimens to a state-wide reference laboratory. The number of virus isolations by the satellite laboratory was slightly greater than from the reference laboratory and the cost was comparable to that of routine bacteriological specimens.
In laboratories where the nature of the patient population is such that HSV is most frequently encountered, the most sensitive cell systems appear to be nonprimate cells, i.e. rabbit kidney or guinea-pig embryo (GPE) cells (Landry et al., 1982c; Hsiung et aL, 1984) . Since other human viruses generally do not grow well in nonprimate cells, presumptive identification can be made according to cell susceptibility and characteristic CPE. As shown in Table 2 , HSV induces a characteristic CPE in both human diploid fibroblast and RK cells. Cytomegalovirus and varicella-zoster virus (VZV) only replicate in human fibroblasts. Enteroviruses grow best in primary MK (vhereas adenoviruses Advantage has been taken of selective cell-culture systems for presumptive identification of enteroviruses (Hsiung, 1961 (Hsiung, , 1962 Landry et al., 1982b) and more recently for typing for HSV types 1 and 2 (Nordlund et al., 1977) . Because HSV-2 produces plaques in both GPE and chick embryo (CE) cell cultures whereas HSV-1 induces plaques in GPE cells but not in CE cells, the two virus types can be easily identified when these two cell systems are used. However, IF with type-specific monoclonal antibodies is now available, is more rapid and as accurate as selective cell systems (Balkovic and Hsiung, 1985) . Those viruses not identifiable by cell susceptibility or characteristic CPE can be referred to larger reference laboratories for final identification.
Although the number of community hospitals with virology laboratories is increasing yearly, the majority still do not have in-house viral cultures available. Therefore, if an accurate viral diagnosis is to be made, specimens must be sent out to reference laboratories or commercial laboratories for virus isolation. With the ready availability of overnight rapid delivery services, specimens can now be processed promptly with results comparable to in-house processing (Ray and Minnich, 1982) . In addition, with a new specimen transport device using human fibroblast cell cultures, virus may replicate during transport (Warford et al., 1984) .
RECENT ADVANCES IN VIRUS ISOLATION
With the increased utilization of virus isolation comes a demand for improved isolation rates and more rapid results. Therefore, common diagnostic procedures are being re-evaluated in an attempt to optimize the collection and transport of specimens, specimen processing, the conditions of culture incubation and the selection of the most sensitive cell culture system for each virus.
Specimen Processing
Different processing methods have been examined to determine the optimum for detection of enterovirus viremia (Prather et al., 1984) , and the factors influencing recovery of varicella-zoster virus (VZV) have also been studied (Levin et al., 1984) . A number of studies have determined the importance of centrifugation of specimens onto the monolayer. Improved isolation rates and more rapid results for HSV and CMV have been reported (Gleaves et al., 1984 (Gleaves et al., , 1985a Salmon et al., 1986) . Fractionation of semen with inoculation of the pellet fraction into culture has been associated with elimination of monolayer toxicity and enhanced CMV detection in AIDS patients (Howell et al., 1986) .
Cell Culture Selection and Conditions of Incubation
A continued search for better culture systems for each virus remains an important task of the diagnostic virologist. Recent reports have indicated that a mink lung cell line is highly sensitive to infection with HSV (Fayram et al., 1985; Smith et al., 1985) . In another study MRC-5 cells were found to be more sensitive than WI-38 for CMV isolation (Gregory and Menegus, 1983a) .
Incubation temperature has long been recognized as important in the isolation of respiratory viruses, for which 33°C is optimal. Recently, it has been reported that 36°C when used for isolation of cytomegalovirus (CMV) results in doubled isolation rates and more rapid onset of CMV CPE, by an average of 4 days (Gregory and Menegus, 1983b) .
Cultivation of Fastidious Viruses
Perhaps the most important development in virus isolation has been the cultivation of several viruses previously considered not amenable to isolation in cell culture. Hepatitis A virus (HAV) has now been isolated directly from fecal extracts in several cell culture types (Provost et al., 1981; Daemer et al., 1981; Siegl et al., 1984) . Since the virus is not cytopathic, immunologic assays such as radioimmunoassay (RIA) or IF are necessary to detect its presence. Human rotavirus was able to be cultivated in cell cultures when trypsin was added to the media and now has been successfully isolated and propagated in several different cell cultures (Graham and Estes, 1980; Naguib et al., 1984) ; IF was the most reliable method for detection and identification of rotavirus in culture. Several enteric adenoviruses, first detected by electron microscopy and considered fastidious, have now been isolated and propagated in several cell systems, with 293 cells considered the most sensitive (Brown et al., 1984) . Ability to isolate these viruses in cell culture greatly facilitates the study of these viruses, allows antigen production and makes way for the development of vaccine(s). However, for diagnostic use, other methodologies, such as serology for detection of HAV IgM antibody and ELISA for detection of rotavirus antigen, remain the methods of choice.
The initial isolation of the human immunodeficiency virus (HIV) was a discovery central to the identification of the causative agent of AIDS and to the development of simpler screening tests for this virus (Barre-Sinoussi et al., 1983; Gallo et al., 1984; Levy et al., 1984) . The mainstay for diagnosis of human immunodeficiency virus (HIV) is detection of viral antibody by ELISA, with positive serum samples retested with supplementary tests such as the Western blot, IF and radioimmunoprecipitation (Schupbach et al., 1986) . However, detection of viral antibody alone does not determine whether the individual is currently infected with the virus. In addition, antibody may not develop for six to twelve months after infection or may become undetectable late in the course of AIDS. The isolation of virus from the infected individual can serve this purpose. However, it remains an elaborate, labor intensive, and lengthy process, that is currently performed primarily in specialized research centers. The procedures for isolation have recently been reviewed elsewhere (Schupbach et al., 1986; Griffith, 1987) (Fig. 3 ). Briefly, human mononuclear cells are separated from the peripheral blood of normal donors, and suspended in growth media containing a mitogen such as phytohemagglutinin and a T-cell growth factor such as interleukin 2. Several days after lymphocyte cultures have been initiated, patients' specimens are inoculated and are then observed for 3 to 4 weeks for viral cytopathic effect ( Fig. 4 ) and the supernatants are assayed weekly for the products of viral replication such as reverse transcriptase or viral antigen. Freshly prepared stimulated lymphocyte cultures are added once a week. Although continuous cell lines are available that support the growth of HIV, these lines are not as sensitive as primary lymphocyte cultures for isolation of virus from patients' specimens . Continuous cell lines have the advantage however of showing little CPE and producing large amounts of virus and thus are essential for the production of viral antigens for diagnostic tests. Other human Although isolation of HIV is currently too tedious and expensive for routine diagnostic use, with anticipated methodologic improvements it will certainly play a larger role in the future.
ADVANCES IN VIRUS IDENTIFICATION
After preliminary identification of virus isolates by CPE in cell culture, final identification has required labor-intensive neutralization, hemagglutination inhibition or complement fixation tests. Despite the time invested, the results of these tests are not always clear-cut. In addition, with the increasing importance of viral diagnosis in patient care, more rapid specific identification is needed, as mistakes or delays in identification can adversely affect treatment and patient management. 
Monoclonal Antibodies

RNA Genome Analysis
In recent years, a number of the tools of molecular geneticists have been used for the identification and fingerprinting of RNA and DNA viruses. Oligonucleotide mapping and polyacrylamide gel electrophoresis of viral proteins have been used to determine genetic epidemiologic relationships between polioviruses and have been useful in determining the relations between cases of paralytic polio and vaccine strains of polio (Minor, 1980; Nottay et al., 1981) . Oligonucleotide mapping has also been used to study the evolution of influenza A virus strains in nature (Nakajima et al., 1978; Nakajima et al., 1980; Young and Palese, 1979) . Electropherotyping of human rotavirus strains has been used to identify strains involved in disease outbreaks within hospital settings and in different parts of the world (Albert et al., 1982; Chiba et al., 1984; Rodger, et al., 1981; Rodriguez et al., 1983; Spencer et al., 1983) . This technique has been useful in confirming the difference in rotavirus strains isolated in China from previously recognized rotavirus strains (Hung et al., 1984) .
Restriction Endonuclease Analysis
In recent years, restriction enzyme analysis has been used to identify and classify DNA viruses of the herpes-, adeno-and papovavirus groups. By this technique, viral DNA is incubated with a specific endonuclease resulting in cleavage of all susceptible DNA sequences. Then the fragments are separated by gel electrophoresis and a characteristic 'fingerprint' for that virus is obtained (Summers, 1980) . The application of restriction endonuclease analysis has been particularly useful in the study of HSV. HSV-1 and HSV-2 can be readily distinguished by this technique and it is considered the gold standard for typing isolates (Mayo et al., 1985b) . In addition, strain-specific differences are evident, allowing further subclassification of isolates within an HSV type ( Fig. 5 ). As a result, restriction endonuclease analysis has proved useful in the typing of HSV-1 and HSV-2 isolates on a large scale (Lonsdale, 1978) , in tracing nosocomial outbreaks of HSV Linneman et al., 1978) , and in dispelling concern that a clustering of cases of herpes encephalitis was due to circulation of a single neurovirulent strain of virus (Landry et al., 1983) . The same methodology has now been applied to tracing sources of CMV infection (Wilfert et al., 1982; Yow et al., 1982; Handsfield et al., 1985) , as well as studying the molecular epidemiology of VZV (Martin et al., 1982) and adenoviruses (Kemp et al., 1983; Wadell et al., 1985) . Restriction enzyme analysis has also been shown to be more reliable and specific than neutralization and hemagglutination tests for the identification adenoviruses (Fife et al., 1985a,b; Hammond et al., 1985) . Thus, restriction endonuclease fingerprinting provides a useful additional method for virus identification.
LIGHT MICROSCOPY
Direct smears from skin lesions have long been useful in the rapid diagnosis of HSV, VZV and poxvirus infections. HSV and VZV both induce multinucleated cells and characteristic intranuclear inclusions (Cowdry type A), whereas poxvirus infections induce typical cytoplasmic inclusions (Guarnieri bodies) in infected cells. Where no viral culture facilities are available, Pap smears have also been used to detect the presence of HSV infection of the cervix. Characteristic CMV-induced intranuclear inclusions in both Pap smears and infected tissues have been used as markers for diagnosis of CMV infections. For certain virus infections, the cellular changes themselves in the affected organs are sufficiently characteristic to permit a presumptive diagnosis. Examples are the spongiform degeneration in the brains of patients with Creutzfeld-Jacob disease (Gibbs and Gajdusek, 1969) and the balloon degeneration of liver cells seen in viral hepatitis (Ishak, 1976) . The recent commercial availability of high-quality immunologic staining reagents and nonradioactively labelled viral probes for in situ hybridization has allowed a more specific and sensitive diagnosis of viral infections to be made using tissue sections in a routine pathology laboratory (see Section 3).
ELECTRON MICROSCOPY AND IMMUNE ELECTRON MICROSCOPY
The electron microscope (EM) has been used in the diagnosis of viral diseases for several decades. Only by this method can a virus be directly visualized. Virus size and shape can be easily identified (Figs 6 and 7). However, different viruses with the same morphology cannot be distinguished by routine examination (e.g. smallpox and vaccinia, or HSV and VZV).
The EM techniques most commonly used include the negative staining of virus particles with the electron-dense salts of phosphotungstic acid (Figs 6 and 7, top row) or preparation of uitrathin sections of cells or tissues suspected of harboring virus (Figs 6 and 7, middle row). Clinical specimens or virus-infected culture fluid can be examined directly using the negative staining technique, thus providing a rapid diagnosis of virus infection (Hsiung et al., 1979) . However, difficulties are encountered when the number of virus particles in the sample examined is low. A number of techniques have been developed to enhance virus visualization, including the pseudoreplica technique (Smith and Melnick, !962), agar gel diffusion (Anderson and Doane, 1972) and ultracentrifugation (Smith and Gehle, 1969) . Although thin sectioning of tissues usually requires 3 or more days of specimen preparation for EM, a more reliable diagnosis may result since the fine structure of the virus particles and cells is more likely to be preserved. This may be especially important in cases where very few virus particles may be present or in determining the location of the virus particles. The recognition of a human papovavirus in the brain cells of a patient with progressive multifocal leukoencephalopathy (ZuRhein and Chou, 1965) and the identification of Epstein-Barr virus in cultured lymphoblastic cells derived from a Burkitt's lymphoma patient (Epstein et al., 1964) would have been missed had not this EM technique been used. @ ENTERO- In the 1970s, the application of EM techniques uncovered a number of new viruses which could not be isolated in culture. These included hepatitis B virus (Dane et al., 1970) , enteric adenoviruses in the stools of children with gastroenteritis (Flewett et al., 1975) , and, with the use of immune electron microscopy (IEM), hepatitis A (Feinstone et al., 1973) , rotavirus (Flewett et al., 1973) and Norwalk agent (Kapikian et al., 1972) were first visualized in stool contents. IEM, which involves the mixing of the patient's specimen with immune serum resulting in aggregation of viral particles rendering them readily visible, has also been useful in the rapid diagnosis of respiratory viruses in clinical specimens (Doane et al., 1967; Joncas et al., 1969) .
Recent innovations have included the development solid-phase IEM by the use of protein A, which was found to be 30 times more sensitive than EM and 10 times more sensitive than ELISA for the detection of rotavirus in stools (Svensson et al., 1983) . Another modification is the use of the solid-phase IEM double-antibody technique, by which formvar carbon-coated grids are treated with diluted antibody, resulting in approximately 30-fold increase in virus particles. Viewing of the virus is facilitated by the addition of a second 'decorator' antibody. This has been used with success in the detection of papovaviruses (Giraldo et al., 1982) . However, despite the many contributions of EM and IEM to virus diagnosis, it is still too expensive and cumbersome for routine application in the average diagnostic laboratory.
RAPID VIRAL DIAGNOSIS
The rapidity with which the isolation of a virus can be accomplished is variable and depends upon the virus type, the amount of virus in the clinical specimen and the sensitivity of the culture system utilized. Certain viruses, such as HSV, can often be isolated within 24 hr of inoculation into cell culture, whereas other viruses require 7 or more days for isolation and some have not been amenable to culture by routinely employed methods. The delay encountered in the diagnosis of many common virus diseases has been a source of frustration to both physicians and laboratory personnel. With the advent of antiviral chemotherapy, this dilemma has become more acute. In order to have a beneficial effect on the outcome of an illness, therapy must be instituted early. This has led to tremendous interest in the development of so-called 'rapid viral diagnostic methods'. The formation of both European and Pan American groups for rapid viral diagnosis with regular symposia to keep members abreast of recent advances in the field is a direct result of this interest (Mclntosh et al., 1978 (Mclntosh et al., , 1980 Richman et al., 1984a,b) . Ideally, rapid diagnostic methods should be capable of yielding results within a few hours of a patient's admission to the hospital with testing performed directly on clinical material. However, test results obtained within 1-2 days of admission would render viral diagnostic methods comparable to those routinely used in microbiology laboratories. Such 'rapid' techniques would include those used to identify viral antigens or nucleic acid directly in clinical specimens or after amplification of virus in cell cultures before cellular changes occur or in cases where no changes occur.
Many of the techniques to be discussed in this section have an immunologic basis, i.e. they depend upon the specific reaction between antigen and antibody. The reaction must be labeled with a marker to render it detectable. The marker can be a fluorescent dye, a radioisotope or an enzyme such as peroxidase. An important development leading to the increased utilization of immunologic detection techniques have included the availability of high-quality commercial reagents including monoclonai antibodies.
Another significant and very recent change in the field of rapid viral diagnosis has been the introduction of nucleic acid hybridization technology into the field of clinical virology. Recent advances that have allowed the application of these techniques include: first, molecular cloning, resulting in the production of well-characterized and specific reagents for use as probes; second, the recognition of the ability of nucleic acid to bind to nitrocellulose, which allows screening of large numbers of samples; and, third, the development of non-radioactive biotinylated probes suitable for use in clinical laboratories. Hybridization techniques in clinical diagnosis remain experimental at this time; however, owing to the tremendous interest that exists in this area and the proliferation of studies published in the last few years, an overview will be presented.
The immunologic and hybridization techniques will be reviewed in terms of their application to both direct detection of viral antigens or genomes in clinical specimens and detection of virus infection after amplification in cell culture. In general, for viruses that replicate well in cell culture, direct detection methods ae less sensitive though more rapid than virus isolation. However, application of these methods to infected cell cultures can significantly shorten the time to reporting positive results and, in addition, confirm the identification of the virus.
It must be emphasized however, that all of the techniques discussed in this section are directed at specific viruses that are 'suspected'. They are not 'open minded', only virus isolation and EM will lead to the discovery of 'unsuspected' or 'new' viral agents.
VIRAL ANTIGEN DETECTION
Immunofluorescence
Immunofluorescence (IF) techniques, which include the direct fluorescent antibody (FA) procedure and the indirect fluorescent antibody (IFA) procedure, have long been used in the diagnosis of viral diseases. First introduced in 1941, IF was developed specifically to detect antigens in animal tissues (Coons et al., 1941) . By this technique, specific antibody is tagged with a fluorescent dye, allowed to react with the antigen and, after a short incubation, the site of the antigen-antibody reaction can be visualized using a microscope with a u.v. light source.
Direct IF is used to detect antigen by utilizing a specific antibody which is conjugated directly with a fluorescent dye. It is quicker, simpler and exhibits less nonspecific staining than the indirect method. The indirect method utilizes specific antibody that is not conjugated but is allowed to react with the test antigen. Then, conjugated antibody is added which is directed against the animal species from which the primary antibody is made. This test can be used to detect antigen or antibody, and has the advantage of requiring only a single conjugate for the detection of many antigen-antibody reactions provided that all antisera are made in a single species. Although the indirect test is slightly more sensitive, it also gives more nonspecific results.
Many difficulties have been encountered since the introduction of IF techniques, but in recent years many of the problems have been overcome. For example, an adequate number of infected respiratory epithelial cells are essential for respiratory specimens. It is necessary to see labeled intracellular antigen in a distribution (intranuclear or intracytoplasmic) and in the cell type expected for the particular virus. Also, experience is required in distinguishing the nonspecific fluorescence seen with bacteria, fungi and mucus commonly present in respiratory specimens. Proper specimen collection and sample preparation are important in minimizing these problems. For skin lesions, there is little problem in the vesicular stage but once lesions have become crusted, nonspecific fluorescence becomes a problem. In brain biopsies, nonspecific fluorescence is not usually problematic, but in autopsy specimens, if bacterial overgrowth has occurred, again experience is required in distinguishing nonspecific fluorescence (Gardner, 1977) . Owing to difficulties in obtaining specific sensitive antisera, it has been difficult to reproduce results outside of the research setting, until now. The availability of quality reagents and the demand for rapid diagnosis have contributed to this change.
IF was first applied to the direct detection of virus in clinical specimens with the identification of influenza A in nasal smears (Liu, 1956) . Subsequently, rabies was detected in mouse brains utilizing this technique and quickly became the method of choice for rapid diagnosis of rabies virus infection (Goldwasser and Kissling, 1958) . In addition, IF has been used to detect HSV in skin lesions (Biegeleisen et al., 1959) . More recently IF has been applied to the detection of a number of viruses including HSV (Schmidt et al., 1980 (Schmidt et al., , 1983 , VZV (Schmidt et al., 1980) , RSV , and parainfluenza (Wong et al., 1982; Waner et al., 1985) in clinical specimens with varied results. It was also by IF that the delta hepatitis virus (HDV) was detected in liver cell nuclei and in serum of hepatitis B virus (HBV) carriers (Rizzetto et al., 1977) . The application of IF using monoclonal antibodies to direct detection of influenza (Shalit et al., 1985) and CMV (Martin and Smith, 1986) in clinical specimens has produced promising results. Perhaps RSV has generated the greatest enthusiasm due to the difficulties encountered with culture and the benefits of rapid diagnosis with the availability of ribavirin treatment Lauer, 1982) . Numerous investigators have found IF examination of nasopharyngeal aspirates using either polyclonal or monoclonal antibodies more sensitive than culture (Cheeseman et al., 1986; Freymuth et al., 1986; Swenson and Kaplan, 1986) .
The advantages of immunofluorescent procedures performed directly on clinical specimens include speed, simplicity, low cost, and the ability to make a diagnosis in convalescence in some viral infections where virus is rendered non-infectious by the presence of antibody but is still visible by fluorescence. The ability to make a diagnosis when specimens have been delayed in their arrival in the laboratory is a great advantage. However, IF is highly dependent on proper collection of specimens. Even under study conditions, a significant percentage of specimens are unacceptable due to inadequate numbers of epithelial cells, which makes the specimen untestable.
IF techniques were also first used years ago for the rapid detection and identification of viruses after amplification in cell cultures. Examples include the rapid detection and identification of measles (Cohen et al., 1955) , VZV (Weller and Coons, 1954) and poliovirus (Kalter et al., 1959) and subsequently rubella (Schmidt et al., 1966) . For this application, there have been a number of exciting and potentially useful innovations within the last two or three years. One group has used centrifugation of specimens onto monolayers in shell vials, followed by application of IF at 36 hr (Gleaves et al., 1984) and then 16 hr post inoculation (Gleaves et al., 1985a) for the rapid detection of CMV in urine. All CMV isolates were detected by IF at 36 or 16 hr respectively whereas an average of 9 days was required for detection of CMV CPE using standard virus isolation without centrifugation or IF staining. When BAL and blood specimens are tested for CMV by this technique, some false negative results are obtained (Paya et al., 1987) . It is also important to inoculate two or, for blood samples, three shell vials per specimen for optimal results (Paya et al., 1988) . The same methodology was applied to the early detection of HSV with excellent results (Gleaves et al., 1985b) . Centrifugation was shown to be important in early detection. However, when this same methodology was applied to rapid detection of influenza virus using monoclonal antibodies, only 56% of influenza isolates were detected at 24 hr post inoculation by IF, compared with an average of 4 days for conventional isolation (Espy et al., 1986) . Another study compared short term (24 hr) tissue culture followed by IF with standard virus isolation and found complete agreement between the two methods. However, when the same reagents were applied directly to clinical specimens, both false-negative and false-positive results were obtained (Nerurkar et al., 1984a) .
Immunoperoxidase
Immunoperoxidase (IP) techniques follow the same principles as IF techniques, however, the conjugate is an enzyme, most often horseradish peroxidase. The enzyme is coupled to specific antibody in the direct method, and to an antianimal species globulin in the indirect test. The presence of the enzyme conjugate bound to the virus-infected cells is detected by adding a substrate, diaminobenzidine or aminoethylcarbazole, then oxidizing it in the presence of hydrogen peroxide resulting in a reddish-brown color which is permanent. The test has the same potential applications as IF and it has a number of advantages over IF: the reaction can be detected with the naked eye or with a light microscope, which is important for laboratories with limited budgets; many of the products are electron dense and thus can be visualized with the electron microscope; most preparations are permanent; the reagents are more readily standardized and are more stable; there are less nonspecific reactions; and IP has been more successful than IF on processed tissue. However, this procedure was first described in the early 1970s (Avrameas and Ternynck, 1971 ) and experience with it is much less extensive than with IF. A major problem has been the endogenous peroxidase present in leukocytes in clinical specimens, especially from the respiratory tract, which leads to nonspecific staining. Techniques have been developed to remove the endogenous peroxidase (Straus, 1971; Weir et al., 1977) , but they can also result in removal of unstable virus antigen, and if there is only a small amount of virus present, a false-negative result can be obtained.
The application of IP techniques to clinical material includes the identification of rabies (Atanasiu, 1975) , HSV in a variety of clinical specimens (Morisset et al., 1974; Schmidt et al., 1983) including brain tissue (Benjamin and Ray, 1975) , measles in the brains of patients with SSPE (Brown and Thormar, 1976) , and hepatitis B in fixed liver sections (Burns, 1975) . It has also been compared to IF for the detection of influenza A and respiratory syncytial virus (RSV) in respiratory specimens (Gardner et al., 1978) . The two techniques were in excellent agreement, but removal of endogenous peroxidase was a significant problem in specimens containing RSV, where removal of peroxidase resulted in loss of RSV antigen. Recent modifications that have resulted in more sensitive assays include the peroxidase-anti~peroxidase (PAP) (Sternberger and Joseph, 1979 ) and avidin-biotin complex (ABC) techniques (Hsu et al., 1981) .
IP methods were used early on to detect viral antigen in cell culture to obtain a more rapid diagnosis (Benjamin and Ray, 1974) and it is for this purpose that it has received much wider application recently. IP has been used to identify rubella isolates in cell culture (Schmidt et al., 1981) . More importantly, commercial kits for HSV cultivation and identification have been developed using Vero cell culture, followed in 48 hr by staining with the PAP technique. Although these kits provide a valuable introduction to virus isolation for those laboratories without virology expertise (see Fig. 8 ), numerous studies have not found them to be as sensitive as standard virus isolation. The sensitivity of the kits has ranged from 73 to 79% when compared with standard tissue culture (Fayram et al., 1983; Hayden et al., 1983; Rubin and Rogers, 1984; Sewell et al., 1984) . However the problem may well lie in the kits' use of Vero cells which are fairly insensitive to HSV infection when compared with more widely used HDF or primary RK cells. When other workers used HDF cell culture followed by IP staining at 24 hr, all HSV isolates were detected at 24 hr by IP staining that were eventually detected by standard culture (Miller and Howell, 1983 ). An additional study demonstrated that it is possible to significantly shorten the time involved in maintaining and observing cell cultures by application of the PAP technique for early detection of HSV in HDF cell culture. Over 16,000 specimens were processed for HSV; essentially all cultures positive for HSV were detected by 72 hr (two-thirds by 24 hr) by PAP staining, resulting in significant savings in time and materials (Mayo et al., 1985a) . The combination of centrifugation of specimens onto cell monolayers followed by overnight incubation and IP staining was found to be more sensitive as well as more rapid than standard cell culture for diagnosis of HSV (Salmon et al., 1986) . Thus this technique has much potential in rapid viral diagnosis, especially for laboratories without a fluorescence microscope.
Enzyme-Linked Immunosorbent Assay
In 1971, Engvall and Perlmann introduced the enzyme-linked immunosorbent assay (ELISA) for the quantitation of rabbit IgG (Engvall and Perlmann, 1971 ), a technique as sensitive as the radioimmunoassay (RIA), but with many advantages over the RIA. ELISA is similar to RIA except that an enzyme is used as the immunoglobulin marker instead of a radioactive isotope. When substrate is added to the enzyme-labelled immunoglobulin, a visible color reaction occurs which can be read visually or quantitated using a spectrophotometer. The ELISA can be used either for detection of antigen or antibody and has several variations modelled after the RIA. For detection of antigen, either the antibody sandwich or the competitive assay can be used. In the antibody sandwich method, specific antibody to the antigen to be detected is used to coat the surface of a solid phase support (such as polystyrene beads, microtiter plates, test tubes, etc.). Then the test sample (e.g. stool, body fluid) is added and allowed to react. For the direct or single antibody sandwich test, enzyme conjugated to specific antibody is then added and allowed to react. For the indirect or double-antibody sandwich test, unlabeUed specific antibody is first added, then enzyme conjugated antiglobulin is added. As a final step, the amount of enzyme bound is detected by the addition of a substrate. The intensity of the subsequent color reaction is proportional to the amount of antigen in the test sample. In the competitive assay, specific antibody is adsorbed to the solid phase and the test specimen is added as above, in addition to a known amount of labeled antigen. The unlabeled antigen in the test specimen competes with the labeled antigen for antibody binding sites. Then substrate is added. The bound enzyme, and resultant color change, is less if antigen is contained in the material. The amount of antigen in the test sample is determined quantitatively by comparing the color obtained to known standards. The two enzymes most widely used in ELISA are horseradish peroxidase (Avrameas and Ternynck, 1971) and alkaline phosphatase (Engvall and Perlmann, 1971) , but a number of others have also been used, each with advantages and disadvantages Hosli et al., 1978; Watanabe et al., 1979) . The problems in ELISA are similar to those in other immunologic tests. The purity, the sensitivity and specificity of the reagents must be carefully controlled. Nonspecific binding is a problem that can be diminished by careful washing, addition of 1~,% species specific serum to the reaction mixture, and the use of high quality specific reagents. The introduction of monoclonal antibodies should also reduce this problem. In addition, the optimal conditions for the assay vary depending on the antigen, enzyme, substrate etc., and must be carefully monitored. Because of the variables, a number of control specimens with known amounts of antigen should always be included in every test.
Since its introduction, the ELISA has been used for the detection of a variety of antigens, antibodies and other biologic substances (Yolken, 1980) . It has been widely applied to viral antibody detection with great success, most notably hepatitis B virus, for which it has supplanted the RIA, and human immunodeficiency virus (HIV). The ELISA has also been used for the detection of viral antigens of viruses which are difficult to propagate in culture, such as a group A coxsackieviruses (Yolken and Torsch, 1980) , human coronaviruses (Macnaughton et al., 1983) , enteric adenoviruses (Anderson et al., 1983) , Norwalk agent (Gary et al., 1985) and hepatitis A (Mathieson et al., 1977; Coulepis et al., 1985) . ELISA, for detection of these viruses, remains a research tool, since there has not been sufficient demand for these tests in clinical laboratories.
To date, ELISA has been especially useful in the diagnosis of rotavirus infections (Yolken et al., 1977) . ELISA kits for rotavirus antigen detection have been available commercially for a number of years now and have been found comparable to EM (Cheung et al., 1982; Rubenstein and Miller, 1982) . Recent modifications have resulted in an even more sensitive rotavirus ELISA kit (Doern et al., 1986) . However, group B rotaviruses recently detected in China (Hung et al., 1984) are not detected by the current commercial ELISA kits.
Hepatitis B virus has not yet been propagated in cell culture which limits laboratory methods to serologic detection of HBV antibodies and antigens and more recently, hybridization for detection of viral DNA. Tests for at least six serologic markers for HBV are available commercially. Determining the pattern of these markers in the individual patient will help to establish the stage of the disease, the infectivity, immune status and prognosis of the patient. The application and interpretation of these tests has been reviewed in detail elsewhere (Chernesky et al., 1984) . The ELISA has also been applied to detection of delta virus antigen and antibody in serum (Crivelli et al., 1981; Shattock and Morgan, 1983; Buti et al., 1986) , which should result in less need for diagnostic liver biopsy in these patients.
ELISA has also been used to detect a number of routinely cultured viruses in clinical specimens such as RSV (Hornsleth et al., 1982; Mclntosh et al., 1982; Freymuth et al., 1986; Swenson and Kaplan, 1986) , influenza A, adenovirus (Harmon and Pawlick, 1982) , HSV in lesion swabs (Morgan and Smith, 1984; Nerurkar et al., 1984b; Warford et al., 1984) and HSV in cerebrospinal fluid of patients with encephalitis (Coleman et al., 1983) . When used for direct detection of HSV in clinical specimens, ELISA was not sufficiently sensitive when compared to cell culture results (Sewell and Horn, 1985) . However, when applied to HSV infected cell lysates, results were significantly improved (Morgan and Smith, 1984) . ELISA could prove useful for the rapid and early identification of HSV when large numbers of cultures are processed. The most recent innovation has been an HSV ELISA spin amplification technique, in which samples are centrifuged onto monolayers and incubated for 2 days. The cell cultures are then lysed and assayed by ELISA for HSV antigen. This test was found to be highly sensitive and specific (Michalski et al., 1986) .
A significant recent application has been the development of ELISAs to detect the core protein (p24) of the AIDS virus, HIV (Higgins et al., 1986; McDougal et al., 1985) . Although current techniques for the isolation of HIV are more sensitive than antigen detection, they are highly specialized and beyond the capabilities of a routine viral diagnostic laboratory. The ELISA has been used to detect HIV core antigen in serum and cerebrospinal fluid Allain et al., 1986) . The presence of HIV antigen in blood has been found as early as two weeks after infection , whereas development of HIV antibodies may require six months or more. Antigenemia, with a decline in HIV core antibodies, has also been found to precede the onset of AIDS Paul et al., 1987) . Direct detection of viral antigen also is useful in following patients on antiviral therapy, where a decline in core antigen in serum has been demonstrated in patients receiving azidothymidine (AZT) (Chaisson et al., 1986) . The availability of ELISA for detection of HIV antigen, therefore, could provide a useful additional diagnostic test for AIDS virus infections.
The advantages of ELISA include low cost, less specialized equipment, stability of reagents, avoidance of use of hazardous radioisotopes, wide applicability, and the ability to automate the test or read it visually. Its greatest potential is for the testing of large numbers of specimens for the same virus.
Radioimmunoassay
RIA was developed in 1960 and first applied to the detection of insulin levels in plasma (Yalow and Berson, 1960) . Since that time RIA has been utilized to detect a wide variety of biologic substances in clinical chemistry laboratories. It combines the high sensitivity of radioisotope labelling with the specificity and broad applicability of the antigen-antibody reaction. In addition, large numbers of specimens are readily tested. The sensitivity and specificity also depend upon the quality of the reagents before and after labeling and adherence to rigid test procedures. Both a direct and indirect assay can be used, as in IF, IP and ELISA.
RIA has been utilized in the detection of hepatitis B antibody since 1971 (Lander et al., 1971) and hepatitis B antigen since 1972 (Ling and Overby, 1972) . However, in many laboratories, it has now been replaced by ELISA. Besides hepatitis B, RIA has been used to detect viral antigens in infected cells, generally in cell culture (Hayashi et al., 1972 (Hayashi et al., , 1973 Joseph et al., 1976; Laush et al., 1974) , but also in clinical specimens (Forghani et al., 1974 (Forghani et al., , 1978 Halonen et al., 1980) , and to detect viral antibody . The localization of antigen within cells is not possible by this method. RIA has less nonspecific reactivity than the enzymatic methods and its sensitivity could be useful in detecting small amounts of antigen in clinical specimens. However, it has the disadvantage of the deterioration of radioactive isotopes, requiring new reagents and standardization every few months, the hazards associated with the use of radioisotopes, and the expensive equipment required which limits its use to large centers. Owing to increasing concerns about the potential hazards to personnel, the disposal problems associated with radioactive isotopes, and the availability of alternatives of equal sensitivity, utilization of RIA can be expected to decrease.
Latex agglutination
In the past few years, the use of the simple latex agglutination test for the detection of rotavirus has been reported (Cevenini et al., 1983; Haikala et al., 1983) . The sensitivity and specificity compare favorably with ELISA (Hughes et al., 1984; Sambourg et al., 1985; Doern et al., 1986) . By this technique, latex beads are sensitized to a specific antigen by incubation with immune serum or specific IgG. In the case of rotavirus, the test is performed by mixing clarified stool suspensions with the sensitized latex beads, than after a short incubation, examining macroscopically for clumping (agglutination) of the latex beads. Clumping should occur if the rotavirus antigen is present in the stool. The test is not sensitive for detection of small amounts of antigen, but during rotavirus gastroenteritis large quantities of antigen are usually excreted. This test has several potential advantages: it can be performed by unskilled personnel, it is rapid, relatively cheap and may prove useful for screening in doctors' offices or developing countries.
Latex agglutination has also been applied recently to detection of HSV in clinical specimens but it was not found to be sensitive. However, it was very sensitive and specific for positive identification of HSV after the appearance of viral CPE in cell culture (Ignotofsky et al., 1985) .
VIRAL GENOME DETECTION
Nucleic acid hybridization techniques have only recently been introduced into the field of clinical virology and to date they have been applied to studies of viral pathogenesis and to rapid viral diagnosis using clinical specimens (Landry and Fong, 1985) . The principle of hybridization is simple. In its natural state, the DNA molecule is made up of two strands with each base specifically linked by hydrogen bonds to a complementary base on the other strand. The bonds between the bases can be broken by heating, or treatment with alkali, so that the two strands of DNA are dissociated from each other (denatured). However, under proper conditions, the dissociated strands will reassociate with complementary partners. Under test conditions, a labeled single-stranded nucleic acid probe containing the specific sequences being sought is mixed with denatured (dissociated) sample DNA or RNA. If complementary nucleic acid sequences are present in the sample, labeled probe will reanneal with these sequences forming double-stranded 'hybrids' which now contain label. The labeled hybrids can be detected by a variety of methods and quantitated. Current techniques largely involve the hybridization of labeled probe to nucleic acid immobilized on a solid support, such as nitrocellulose. The technique most widely used in research, including studies of viral pathogenesis, has been the Southern blot. By this method, purified DNA samples are first cleaved with restriction endonucleases, the fragments separated by gel electrophoresis and then the DNA is transferred out of the gel and onto a nitrocellulose filter by the method of E. M. Southern (Southern, 1975) . The nitrocellulose is then immersed in a hybridization solution containing labeled probe. After adequate time has elapsed for reannealing to occur, the nitrocellulose filter is removed from the solution and subjected to a series of washes, which can vary in stringency, to remove untreated probe and unstable hybrids. The binding of the labeled probe is confined to distinct bands, corresponding to nucleic acid fragments separated by electrophoresis; therefore it is possible to identify even weak signals as specific.
For detection of viral nucleic acid in clinical specimens, the most widely used technique to date has been the spot or dot-blot. By this method, nucleic acid or cell suspensions are spotted directly onto nitrocellulose filters, in a grid pattern, with or without suction filtration. The obvious advantages are .the speed and simplicity (avoiding restriction enzyme analysis, gel electrophoresis and DNA transfer) and it does not require the laborious extraction and purification of DNA that is necessary for the Southern blot. In addition, large numbers of specimens can be processed simultaneously. However, since visually, only a spot is identified, it is of utmost importance to guard against non-specific results. False positive results in spot hybridizations have been reported due to reactions of residual bacterial plasmid vector sequences in the probe with patients' samples (Diegutis et al., 1986) . Careful attention to stringency of conditions, probe specificity, and positive and negative controls is essential. Spot hybridization has been used to detect a number of viruses in clinical specimens. When applied to detection of less readily isolated viruses, such as VZV, spot hybridization had a greater sensitivity than culture . For CMV, the time to detection was greatly shortened, but 103-105 tissue culture infectious doses (50%) (TCIDs0) per ml were necessary for a positive result (Chou and Merigan, 1982) . In another study spot hybridization was found to be more sensitive than culture for detection of CMV in buffy coats (Spector et al., 1984) . When applied to viruses not routinely isolated, such as rotavirus (Flores et al., 1983) , enteric adenoviruses (Stalhandske et al., 1983 (Stalhandske et al., , 1985 Takiff et al., 1985) , parvoviruses (Clewley, 1985; Anderson et al., 1985) ; papovaviruses (Gibson et al., 1985; Wickenden et al., 1985) and Epstein-Barr virus (Andiman et al., 1983) , spot hybridization could prove useful. Detection of HBV-DNA in serum by spot hybridization correlates with active virus replication (Carloni et al., 1987) . HBV-DNA has been detected in the absence of other serologic markers for HBV infection (Brechot et al., 1985) and thus provides a new diagnostic tool that may be useful in prognosis and therapy (Bonino et al., 1981; Hadziyannis et al., 1983; Bonino, 1986) . However, this technique was not found to be sensitive for the direct detection of viruses readily isolated in culture, such as enteroviruses (Hyypia et al., 1984) and HSV (Redfield et al., 1983) .
A recently reported modification is the 'sandwich hybridization', which is based on the use of two separate nucleic acid fragments, one of which is attached to the filter and the other is labeled. The nucleic acid sequences of both fragments are complementary to that of the nucleic acid sought in the sample, but the two reagents have no sequences in common and therefore do not hybridize to each other. Thus a positive sample attaches to the reagent bound to the filter and then results in a three component DNA 'sandwich' by mediating the attachment of the labeled probe to the filter. Since the sample is kept in solution throughout the process, as opposed to being spotted onto the filter, components contained in crude samples, such as lipids, mucopolysaccharides, proteins etc., which can non-specifically bind nucleic acids, are not fixed to the filter. This allows the processing of crude samples and the assay of either RNA or DNA, but the sandwich method has not been as sensitive as spot hybridization (Ranki et al., 1983; Virtanen et al., 1984) . In addition 32p or 125I were used as labels in most reports to date which is a disadvantage for a clinical laboratory.
Biotinylated probes have now been used for spot hybridization (Hyypia, 1985) and in situ hybridization, in which intact cells, such as paraffin embedded tissues, frozen tissues or touch preps are examined for viral genomes (Brigati et al., 1983; Forghani et al., 1985; Beckmann et al., 1985) . When used for detection of CMV in lung tissue, in situ hybridization was found to be similar in sensitivity to culture and IF with monoclonal antibody and more sensitive than routine histology (Myerson et al., 1984a; Myerson et al., 1984b) (Fig. 9) . In situ hybridization has proven useful in the detection of human papiUomavirus (HPV) in genital tract tissues. HPV has not yet been propagated in cell culture, but over 40 types have been identified by restriction enzyme analysis and hybridization studies. Certain types, such as types 6 and 11, are commonly associated with genital warts, but are rarely associated with cervical cancer, whereas genital infection with other types, such as types 16 and 18, are considered high risk for progression to malignancy (Campion et al., 1986; Crum et al., 1984) . One recent report on detection of HPV infection in clinical specimens, found in situ hybridization with radiolabeled probe inferior to Southern blot and spot hybridization (Caussy et al., 1988 ). Yet others have found in situ techniques with biotinylated probes highly sensitive (Beckmann et al., 1985) . Biotinylated DNA probes are now available commercially to distinguish infection with types 6 and 11, from infection with 'high risk' type 16. This should have an impact on management of patients with cervical dysplasia. In situ hybridization has the advantage that histology can be evaluated at the same time, it gives information about the localization of sequences within a tissue and what cell type is infected, and it can be more sensitive if only a few sequences are present but are concentrated in one area. However, procedures are labor intensive and sampling can be a problem.
In addition to direct detection of viruses in clinical specimens, recent studies have also applied spot hybridization with radioactive probes to the detection of HSV (Stalhandske FIc. 9 . Detection of cytomegalovirus (CMV) infected cells in lung tissue using in situ hybridization with a biotinylated CMV DNA probe. In situ hybridization was performed using a biotinylated CMV DNA probe (Myerson et al., 1984a) and formalin fixed, paraffin embedded lung tissue from a bone marrow transplant patient with pneumonia. CMV infected ceils were rendered readily visible by dark nuclear and cytoplasmic staining. (Photograph courtesy of Dr D. Myerson.) and Petterson, 1982) and enteroviruses (Rotbart et al., 1984) in cell culture lysates. An infectivity titer for enteroviruses of 106--107 TCIDs0 per ml in the lysate was necessary for positive results. When in situ hybridization with a biotinylated cloned DNA probe was compared with avidin-biotin IP staining for detection of HSV infected cells in two different cell systems, IP staining was found to be more sensitive (Landry et al., 1986) . Significantly, when a highly sensitive cell system was used, CPE alone was comparable in rapidity and sensitivity to viral antigen or DNA detection methods applied in a less sensitive cell system.
ANTIVIRAL AGENTS
As knowledge of the biology and biochemistry of viral functions increases, the potential for the discovery of new specific antiviral agents increases accordingly. The current need for accurate, reliable diagnosis of viral infections is to a great extent the result of the discovery and availability of new antiviral agents. Although it is beyond the scope of this review to present a comprehensive report of antiviral chemotherapy, several of the currently available antiviral agents and some of the most promising new antivirals will be discussed.
DRUGS CURRENTLY AVAILABLE
Amantadine
The precise mechanism of action of this compound is not clear although early events of virus penetration and uncoating are almost certainly involved. In vitro, several viruses are sensitive to the antiviral activity of amantadine, a cyclic primary amine, but influenza type A is particularly sensitive. Inhibition of influenza A virus replication occurs with 25 #g/ml or less. One study using a plaque reduction assay, reported that most clinical isolates were sensitive to 0.4 pg/ml or less (LaMontagne and Galasso, 1978) . Early animal studies demonstrated the effectiveness of amantadine in protection of animals from influenza A virus infection. Doses of 0.6-40 mg/kg protected mice against subsequent influenza A challenge. Protection was observed when the drug was started as late as 72 hr after infection but no protection was afforded when administered after 72 hr (Davies et al., 1964) . Amantadine is considered effective for both prophylactic and therapeutic use in humans against all strains of influenza A viruses. Studies have demonstrated that amantadine was approximately 70% effective in preventing influenza and was also effective in treating the disease (LaMontagne and Galasso, 1978) . Signs and symptoms of disease disappeared more rapidly in patients receiving drug when compared with a placebo group. There was also a decrease in duration and quantity of virus shedding in the treatment group. Side-effects, primarily central nervous system symptoms, occurred in 2-5% of patients. More recent studies again have demonstrated the effectiveness of amantadine prophylaxis of influenza A (Pettersson et al., 1980; Younkin et al., 1983) and it is recommended particularly for unvaccinated persons at high risk.
4.1.2. Iododeoxyuridine 5-Iodo-2'-deoxyuridine (IDU) is incorporated into viral DNA in place of thymidine resulting in essentially nonfunctional viral DNA. The nucleotide of IDU may also interfere with various enzyme systems involved in viral DNA synthesis. This mechanism of action is similar to that of other halogenated deoxypyrimidine nucleosides such as bromodeoxyuridine and fluorodeoxyuridine (DeClercq and Torrence, 1978) . Concentrations of IDU which inhibit replication of vaccinia virus by 95% (2.8 #M) have no effect on noninfected cells (Prusoff and Goz, 1975) .
The antiherpetic effect of IDU in vivo was demonstrated in rabbits soon after the discovery of the effects in cell culture (Kaufman, 1962) . Controlled studies in humans followed quickly and confirmed that IDU was effective in treating herpes keratoconjunctivitis Burns, 1963; Laibson and Leopold, 1964) . Toxicity or allergic reactions may occur with prolonged use of IDU and alternative therapy may therefore be necessary (McGill et al., 1974; Amon et al., 1975) . IDU-resistant HSV strains can occur experimentally (Underwood et al., 1965) and such resistant mutants have been isolated from patients (Hirano et al., 1979) . IDU was the first effective antiherpetic drug approved for human use; however, it is too toxic for systemic administration and is not effective topically on skin or mucous membranes. 4.1.3. Trifluorothymidine 5-Trifluoromethyl-2'-deoxyuridine (TFT) exerts the highest antiviral activity of any of the fluorinated pyrimidines (Heidelberger, 1975) . Its mechanism of action (Kalman, 1975) is similar but not identical to that of other pyrimidine nucleoside analogs (see above).
TFT specifically inhibits herpesvirus replication in vitro (Umeda and Heidelberger, 1969) and has been shown to be effective in treatment of herpes simplex virus and vaccinia virus keratitis in rabbits (Kaufman and Heidelberger, 1964) . In clinical trials of TFT treatment of herpes keratitis, it has been shown to be at least as effective as IDU or adenine arabinoside (ara-A) and its use has been associated with fewer side-effects. One trial has shown TFT to be more effective than IDU (Pavan-Langston and Foster, 1977) . Another trial compared TFT to ara-A in the treatment of herpetic ameboid ulcers and found that healing of TFT-treated ulcers was slightly more rapid than that of ara-A-treated ulcers . However, TFT is also too toxic for systemic administration and, like IDU, its use is limited to eye infections.
Adenine Arabinoside
The primary mechanism of action of adenine arabinoside (9-B-D-arabinofuranosyladenine, ara-A or vidarabine) is inhibition of DNA synthesis by inhibition of virus DNA polymerase and incorporation into viral DNA. Both cellular and viral DNA inhibition occurs but inhibition of cellular DNA synthesis is less marked (Muller et al., 1977) . In cell cultures, vidarabine exhibits a broad range of antiviral activity against DNA viruses including HSV 1 and 2, VZV, human CMV as well as other animal herpesviruses and poxviruses (Shannon, 1975) . Topical vidarabine therapy is effective in treating HSV keratitis (see above), but more important is its use in treatment of systemic diseases. An early study demonstrated the efficacy of treatment of HSV encephalitis in mice (Sloan et al., 1968 ) and a similar more recent study found decreased titers of HSV in the brain and prolonged survival of vidarabine-treated mice (Griffith et al., 1975) . Topical treatment of mice inoculated cutaneously with HSV reduced mortality and decreased establishment of latency in sensory ganglia of vidarabine-treated mice if treatment was begun soon after infection (Klein and Freidman-Kien, 1977) . Vidarabine had only a minimal effect on CMV in a murine model (Overall et al., 1976) and resulted in decreased urinary excretion in a human study, but no clinical improvement was apparent (Ch'ien et aL, 1974) . Treatment of VZV infections in man with vidarabine has demonstrated some antiviral effect (Walden et al., 1977) . Some of the most encouraging results utilizing vidarabine have come from the study of HSV encephalitis victims. In 1977, the results of a collaborative encephalitis study demonstrated the efficacy of the drug. Mortality due to biopsy-proven HSV encephalitis was 70% whereas treatment with vidarabine reduced it to 28% (Whitley et al., 1977) .
A follow-up study has confirmed the original observations and established that age and level of consciousness at the start of therapy are two important factors that influence outcome (Whitley et al., 1981) . A beneficial effect of vidarabine treatment on neonatal HSV infection has been reported. It was also suggested that very early institution of therapy might improve outcome of the disease (Whitley et aL, 1980a) , but increasing the dose of drug did not further decrease morbidity or mortality . Thus, vidarabine was the first drug approved for systemic use in serious herpesvirus infections. However, it is not absorbed well after topical administration.
Acyclovir
Acyclovir (ACV), also known as acycloguanosine or 9-(2-hydroxyethoxy-methyl)guanine, is phosphorylated in herpesvirus-infected cells by a virus-coded enzyme, thymidine kinase (TK). The resulting ACV monophosphate is further phosphorylated by cellular kinases to ACV triphosphate. ACV triphosphate is a competitive inhibitor of viral DNA polymerase and may further inhibit viral DNA synthesis by being incorporated into the DNA thereby causing termination of the DNA chain (Elion et al., 1977) . In vitro, ACV inhibits HSV 1 and 2, varicella-zoster and Epstein-Barr viruses. Human CMV has been reported to be sensitive to high levels of ACV in vitro but clinical isolates are usually resistant at levels of drug attainable in patients (Crumpacker et al., 1979) .
Animal HSV experiments using rabbits (Pavan-Langston et al., 1978) , mice (Mayo et al., 1979) , hairless mice (Klein et al., 1979) and guinea-pigs (Landry et al., 1982a) demonstrated the effectiveness and low toxicity of ACV. Human trials followed rapidly. One study demonstrated effectiveness of topical ACV administration in ocular disease .
Another uncontrolled study of patients with neoplastic disease or bone marrow transplants noted improvement in cutaneous or systemic HSV or VZV infections (Selby et al., 1979) . A randomized, double-blind study in bone marrow transplant recipients demonstrated the effectiveness of intravenously administered ACV in preventing the appearance of culture positive HSV lesions. ACV did not cure latent infection as evidenced by appearance of HSV lesions after the cessation of therapy (Saral et al., 1981) . A preliminary report comparing vidarabine with ACV for treatment of neonatal HSV infections suggests that ACV is at least as effective as vidarabine for treatment of these severe infections .
Importantly, topical treatment of human primary genital HSV lesions with a 5% ACV ointment shortened the mean duration of virus shedding and also the time to complete crusting of lesions (Corey et al., 1982) . In addition, short term, oral therapy of both primary and recurrent genital HSV infections significantly reduced virus shedding and time to healing of lesions (Nilsen et al., 1982; Bryson et al., 1983) . Long-term, oral therapy prevents recurrences of genital lesions in most ACV-treated patients as long as therapy is maintained. However, when treatments are discontinued, the recurrence rates are similar to placebo-treated groups . In addition, acyclovir has been reported to be more effective than vidarabine in the treatment of HSV encephalitis (Whitley et al., 1986) .
Ribavirin
Ribavirin (virazole) is a purine analog resembling guanosine with a wide range of activity against both RNA and DNA viruses. The drug interferes with the synthesis of guanosine monophosphate, with resultant inhibition of both RNA and DNA synthesis. Influenza viruses are among the most sensitive to inhibition (Sidwell et al., 1979) .
Ribavirin has been shown to inhibit RSV replication in vitro (Hruska et al., 1980) and in an animal model (Hruska et al., 1982) . Several double-blind studies have shown that aerosol administration of ribavirin to infected infants resulted in more rapid improvement in overall severity of illness and increased disappearance of RSV from respiratory secretions. There was no evidence of intolerance or toxicity in the treated babies Taber et al., 1983) . This drug has been approved for aerosol treatment of infants and young children with severe lower respiratory infections due to RSV. The trisodium salt of phosphonoformate (PFA) inhibits herpesvirus DNA polymerase at levels of drug which do not appreciably affect cellular polymerase. In cell culture, 100mi PFA inhibits herpesvirus replication by 59-96% depending on the virus (Helgstrand et al., 1978; Reno et al., 1978; Larsson and Oberg, 1981) . This mechanism of action is the same as that of phosphonoacetate (PAA) but PFA is preferred because of the dermal toxicity associated with topical PAA application (Harris and Boyd, 1977; Alenius and Oberg, 1978) . Recent in vitro studies have demonstrated greater activity against HSV-1 and HSV-2 when PFA was used in combination with 5-methoxymethyldeoxyuridine than when either drug was used alone (Ayisi et al., 1985) .
In animal models, PFA is effective in treating cutaneous herpes in guinea-pigs (Alenius and Oberg, 1978) , herpes keratitis in rabbits (Alenius et al., 1980) , and genital herpes in guinea-pigs (Alenius and Nordlinder, 1979) . In the latter genital herpes model in guinea-pigs, treatment was effective only if begun within 24 hr after infection.
A more recent investigation has found that PFA treatment can also be effective in the treatment of guinea-pig genital herpes when begun near the time of appearance of symptoms Lucia et al., 1983) . A double-blind controlled study on cutaneous labial herpes in humans has similarly demonstrated a beneficial effect of PFA treatment on duration of HSV-induced lesions (Wallin et al., 1980) . There have been some concerns, however, about long-term deposition of the drug in bone.
Bromovinyldeoxyuridine
Bromovinyldeoxyuridine (BVDU) is a nucleoside analog which is preferentially incorporated into viral DNA. HSV TK is involved in this preferential incorporation because TK mutants of HSV-I are resistant to the effects of BVDU. Although active against both HSV-1 and HSV-2 in vitro, BVDU inhibits HSV-2 at a concentration that is 100 times greater than that necessary to inhibit HSV-1 (DeClercq et al., 1980b) . The preferential inhibition of HSV-1 may be due to the different rates at which the virusassociated kinases catalyze the second step of BVDU phosphorylation from the monoto the diphosphate (Fyfe, 1982) . BVDU has been found to be nontoxic and effective in topical treatment of experimental herpes keratitis in rabbits (Maudgal et al., 1980) , orofacial herpes in mice (Park et al., 1982) and cutaneous herpes in guinea-pigs (Freeman et al., 1985) . Oral administration has been used in humans to treat herpes zoster (DeClercq et al., 1980a) . No drug-induced toxicity was found in the patients studied while progression of lesion formation was arrested within 24 hr after the start of therapy. Topical treatment of ocular HSV and VZV infections has been shown to be very effective (Maudgal et al., 1984) .
Fluoropyrimidines
The fluoropyrimidines, FIAC (1-(2'-deoxy-2'-fluoro-B-D-arabinofuranosyl)-5-iodocytosine), FIAU (1-(2'-deoxy-2'-fluoro-B-I~-arabinofuranosyl)-5-iodouracil) and FMAU (1-(2'-deoxy-2'-fluoro-B-D-arabinofuranosyl)-5-methyluracil) inhibit HSV-1 and HSV-2 replication in cell culture. FIAC and FMAU are equally active against HSV-1 and HSV-2 strains and have about the same potency as ACV when assayed in rabbit kidney cells (DeClercq et aL, 1980b; Trousdale et al., 1983) . The mechanism of action is believed similar to ACV in that triphosphate nucleotide analogs bind to virus DNA polymerase, may act as chain terminator for viral DNA replication and HSV TK-negative mutants are many fold less susceptible to inhibition.
Animal studies have shown FIAU and FMAU to be more active than ACV in treatment of HSV encephalitis in mice (Schinazi et al., 1983) . In rabbits, topical application of FIAC and FMAU was effective in the treatment of eye infections (Trousdale et al., 1981 (Trousdale et al., , 1983 .
A guinea-pig model of genital HSV infection compared FIAC, FIAU, FMAU, ACV and PFA and found that the three fluoropyrimidines were all more effective than either ACV or PFA for treatment of primary genital HSV-2 infections. FMAU was the most effective of all the drugs tested . In humans, FIAC was reported to be therapeutically superior to ara-A for treatment of VZV and HSV infections in immunosuppressed patients .
Dihydroxypropoxymethylguanine
The compound 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG) is also known as BIOLF-62, 2'NDG and BW759. This acyclic nucleoside is structurally related to ACV and has a similar mode of action against the herpes group of viruses in vitro (Ashton et al., 1982; Cheng et al., 1983; Martin et al., 1983) . In vivo, mouse models have shown DHPG to be very effective, more so than ACV, for the treatment of encephalitis and vaginitis due to HSV-2 . DHPG is also effective against HSV-2 in a guinea-pig model of primary and recrudescent genital herpes (Fraser-Smith et al., 1983) . When compared with ACV, however, DHPG is more toxic, but it has increased activity against both Epstein-Barr virus and CMV. This increased activity against CMV makes DHPG unique, although there are variable reports as to the degree of such activity (Cheng et al., 1983; Smith et al., 1982; Freitas et aL, 1985; Shanley et al., 1985) . DHPG appears to be effective in controlling CMV associated retinitis and colitis as long as treatment is continued (Masur et al., 1986) .
Azidothymidine
Azidothymidine (Y-azido-Y-deoxythymidine or AZT) is a nucleoside analog which competitively inhibits the reverse transcriptase of HIV in cell culture and also inhibits infectivity and cytopathic effect in vitro. Concentrations which effectively block in vitro infectivity and CPE of HIV do not affect in vitro immune functions of normal human T-cells (Mitsuya et al., 1985) . In clinical trials with AIDS and ARC (AIDS-related complex) patients, there were 19 deaths among the 137 patients receiving placebo and one death among the 145 patients receiving AZT. There also appeared to be fewer opportunistic infections in the AZT group (Fischl et ai., 1987) . Additional trials are underway .
In another study, AZT treatment was associated with a significant decrease in HIV core antigen in the serum of AZT treated patients compared with untreated controls (Chaisson et al., 1986) . As a result, AZT has been made available on an investigational basis to AIDS patients who have had Pneumocystis carinii pneumonia and who satisfy certain other criteria. AZT also has excellent penetration across the blood-brain barrier, which hopefully will benefit patients with HIV-associated neurologic disease . Unfortunately, bone marrow toxicity can be a significant problem.
DRUG SENSITIVITY TESTING
Drug sensitivity testing of clinical isolates is an important function of microbiology laboratories and is essential for the administration of appropriate and effective drugs. Antiviral susceptibility testing will also be necessary and is within the capability of the virus laboratory, but performance standards need to be established. Two methods are commonly used in the laboratory for testing drug sensitivity of a given virus. One of the methods is to determine the virus yield in liquid culture medium. Basically this is done by adding varying concentrations of drug to the culture medium of virus-infected cells and assaying aliquots of the medium for the yield of virus. The resulting reduction of virus yield can be plotted against virus yield without drug. The second and perhaps the simplest method of antiviral assay which can be performed by a routine laboratory is a plaque reduction assay. Plaque formation in the absence of the test drug is compared to plaque formation in the presence of the drug at different concentrations (Fig. 10 ). It should be noted that different results are obtained when different cell culture systems are used for the plaque reduction assay. As illustrated in Fig. 10 , a 0.25/AM concentration of ACV is necessary to inhibit 80% of HSV-2 induced plaque formation when CE cells are used for the assay, whereas 4 ,UM of the same drug is needed to inhibit the same amount of virus when GPE cells are used. Thus, the importance of selection of the cell culture system used for drug sensitivity tests is apparent.
Rapid techniques such as nucleic acid hybridization screening (Gadler et al., 1984) and automated CPE inhibition assays (Moran et al., 1985) are now being applied to drug sensitivity testing and can significantly facilitate the ease with which large numbers of antiviral agents can be tested for effectiveness against virus isolates.
THE IMPORTANCE OF ACCURATE VIRAL DIAGNOSIS
To the practising physician, in the absence of specific treatment, there seems to be little to be gained from diagnosing viral diseases. However, for the following reasons, an accurate viral diagnosis can benefit both the individual patient and the public at large.
PATIENT MANAGEMENT
Although no treatment is available for the majority of viral illnesses, obtaining an accurate diagnosis still has important implications for patient management. When the exact etiology of an illness is known, unnecessary and often uncomfortable diagnostic procedures, as well as unwarranted antibiotics, can be avoided, and in addition, the physician can more effectively manage any problems that may arise.
PROGNOSIS
In addition to aiding the management of the acute illness, an accurate viral diagnosis allows for prognostication. The expected course of the illness can be described. This would be particularly important in congenital infections such as rubella and CMV. In genital herpes simplex infection, the patient and contacts should be advised about risk of recurrency, especially in relation to pregnancy, infections of newborns, as well as the increased risk of cervical cancer. In genital HPV infections, detection of low risk or high risk HPV types would be critical in determining potential for progression to cervical cancer.
PROPHYLACTIC AND THERAPEUTIC INTERVENTION
In certain situations, prophylactic intervention is critical. Pregnant women with a history of genital herpes, infection with herpes below the waist or a sexual contact with genital herpes should be monitored frequently with cervicovaginal cultures for HSV the last 4-8 weeks of pregnancy (Visintine et al., 1978) . If HSV is isolated with the week prior to delivery, caesarean section should be performed within 4 hr of the rupture of the membranes to prevent infection of the fetus. Knowledge of the immune status to CMV of kidney transplant recipients and donors is critical for a successful outcome. Seronegative recipients receiving kidneys from seropositive donors have a significant risk of contracting CMV infection and of rejecting the kidney (Lopez et al., 1974; Ho et al., 1975) . Passive immunization with immunoglobulin is available for certain serious infections, such as hepatitis contacts, immunosuppressed children exposed to VZV, and is combined with vaccination in persons exposed to rabies. Amantadine, as discussed above, can prevent or lessen the severity of infection with influenza A and has been useful in protecting unvaccinated, high risk populations.
As described in the preceding section, specific antiviral therapy is now also possible for serious herpes infections such as herpes simplex encephalitis, neonatal infection with HSV, and VZV infections in the compromised host with acyclovir or adenine arabinoside. HSV keratitis can be treated with topical IDU, vidarabine, ACV, or TFT. Acyclovir has also proved of benefit in treatment of genital herpes infections. Ribavirin therapy is effective in treatment of lower respiratory RSV infection in young children. In addition, newer and more promising drugs are being developed.
CONTROL OF NOSOCOMIAL INFECTIONS
Nosocomial viral infections, an important cause of morbidity and mortality in hospitalized patients, can be best prevented when an accurate viral diagnosis is obtained and the medical staff are educated as to the proper precautions to prevent spread of the disease. In-hospital transmission of numerous virus infections has been documented. These include influenza (Blumenfeld et al., 1959) , respiratory syncytial (Hall et al., 1975) , parainfluenza (Mufson et al., 1973) , enteroviruses (Gear and Measroch, 1973) , rotaviruses (Ryder et al., 1977) , varicella-zoster (Meyers et al., 1979) , herpes simplex (Linneman et al., 1978) , hepatitis viruses (Matthew et al., 1973; Postic et al., 1978) , rubella (Carne et al., 1973) , and adenoviruses (Barret al., 1958) . The newborn infant and the compromised host suffer the most serious consequences. When the offending agent is identified, proper precautions can be instituted.
PUBLIC HEALTH MEASURES
The importance of viral diagnosis in public health has long been recognized, as illustrated by the control of hepatitis, arbovirus and rabies infections. It has been the major impetus behind effective vaccination programs and allows for the continued evaluation of the efficacy of current vaccines. Continued surveillance is particularly important in determining the antigenic composition of influenza vaccines.
ADVANCEMENT OF MEDICAL SCIENCE
Since 1970, we have witnessed the discovery of rotaviruses (Flewett et al., 1973) , Norwalk agent (Kapikian et al., 1972) , JC and BK papovaviruses (Padgett et al., 1971; Gardner et al., 1971) , delta agent (Rizzetto et al., 1977) , and the recognition that non-A, non-B hepatitis viruses account for the majority of transfusion associated hepatitis (Hoofnagle et al., 1977) . The most dramatic discovery however, has been that of HIV as the etiologic agent of AIDS (Barre-Sinoussi et al., 1983; Gallo et al., 1984; Levy et al., 1984) . Viruses have been implicated in many well known diseases, such as Paget's, polymyositis, chronic neurologic syndromes, autoimmune diseases, diabetes, and cardiomyopathy. Although perhaps not of immediate benefit to the patient, enlarging our knowledge and understanding of the pathogenesis and spectrum of virus-induced diseases will lead to improvement in medical care in the future.
PHYSICIAN EDUCATION
A final and very important reason for obtaining an accurate viral diagnosis is the education of physicians. Because of the lack of therapy, it has not been important for physicians to be well versed on the specifics of many viral diseases. It has been adequate to diagnose a 'viral syndrome'. When specific diagnoses are obtained, the physician is stimulated to learn more. As we approach an age of chemotherapy, the increased clinical acumen of the physician in diagnosing viral disease will be decidedly more important.
CONCLUDING REMARKS
Since the discovery of tissue culture over 40 years ago, many changes have occurred in the field of diagnostic virology. Interest in different virus groups has fluctuated tremendously (Hsiung, 1980) , there have been significant technological advances and many 'new' viruses have been discovered (Hsiung, 1984) of which HIV and other human retroviruses are the most striking example. Nothing, however, will have a greater impact on diagnostic virology than the availability of effective chemotherapy. Until recently, virus laboratories have existed either as part of health departments or university research laboratories and their services have not been readily available to community hospitals or practising physicians. However, over the next decade, with the expected progress in antiviral therapy, significant changes can be anticipated. Since minimal amounts of virus may be present in clinical samples, transporting them to a reference laboratory can result in loss of infectious virus and even negative findings. With facilities close by, time to virus isolation and numbers of isolations can be optimized. If significant numbers of specimens are processed, cost will be favorably affected. In addition, communication between the laboratory and physician will be facilitated. Several recent reports have demonstrated the feasibility of establishing satellite or mini laboratories (Herrmann and Herrmann, 1977; Peterson et al., 1980) or laboratories operated on a small scale (Landry and Hsiung, 1981) whose services are tailored to the needs of the patient populations they serve. High-quality commercial reagents are now becoming available for many rapid diagnostic methods. Continued progress in this area can be anticipated in the near future as the need increases. As we become more optimistic about our ability to intervene in the course of viral diseases a greater need to obtain an accurate viral diagnosis is evident.
